SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Ott " 21,927 found 🔀 AI-powered Shuffle
Behind the Scenes with Kaitlan Collins: Trump welcomes Xi Jinping amid White House press restrictions
Supreme Court again blocks Missouri's new map drawn to give Republicans an edge
Cotton candy catering: Kiffany Bosserman refined her taste for business (and the value of her time)
After nearly a decade in business, Cottontale KC is still spinning sugar into a confection for success, shared founder Kiffany Bosserman — pivoting her business to say “yes” less and reprioritize the balance of family and life and profitability.
Vacant South Philadelphia property pipe leak creates 8-inch deep "pond" in nearby business lot
Yearlong water leak at vacant South Philly property ruins nearby business lot
3 Questions for 76ers Heading Into Training Camp
Training camp is close, and this team has so many questions to answer. It's going to take more than one game to get to the bottom of these crucial questions.
“Same confidence”: Ho targets response after West Ham
Tottenham Hotspur return to league action on Sunday against Aston Villa, with Martin Ho using Friday’s press conference to reflect on how rotation disrupted his side’s rhythm in their last outing ...
Cook Political Report Gives Major Update on House Races — But It’s Not All Good News for Dems
Brian Schottenheimer: "This Is a Business Trip"
Head coach Brian Schottenheimer discusses the Cowboys' preparation for their international matchup against the Baltimore Ravens, emphasizing the challenges posed by Lamar Jackson and Derrick Henry, the importance of communication on defense, and rookie Ja
Brian Schottenheimer's message to Cowboys in Rio: 'It's a business trip'
Rio is one of the most beautiful places in the world, but as the Dallas Cowboys prepare to take on the Baltimore Ravens in Brazil, the message from Brian Schottenheimer is crystal-clear.
How worried are Republicans about the midterms? GOP Senators demand Congress stay in town for a vote on affordability
Cook Political Report Gives Major Update on House Races -- But It's Not All Good News for Dems
Illinois measles cases hit 23 in 2026, most from Douglas, Moultrie counties outbreak
Quick hitters: O-line health, safety depth and Dan Campbell’s first days in Detroit with Glenn
Allen Park — Detroit Lions coach Dan Campbell and quarterbacks coach Mark Brunell met with the media on Friday. Here are the noteworthy items from those conversations. Healthier up front, banged up in the back It’s good news, bad news on the injury front. First, the offensive line is going to be far closer to full strength with starters Blake Miller (knee) and Christian Mahogany (hip) on track to return to the lineup. That provides stability the offense lacked against Buffalo, particularly at right tackle, where backup Larry Borom allowed 11 quarterback pressures and committed a trio of penalties. Subscribe However, with that same unit, veteran Ben Bartch (foot) is likely to miss Sunday’s matchup with the Jets. The left guard competition that’s been ongoing since May has effectively been whichever option is healthy that week. In the back end, safety Thomas Harper (ankle) is also unlikely to be available on Sunday. That leaves the team precariously thin at the position following Avonte Maddox going on injured reserve this week. Christian Izien is expected to get the start alongside Chuck Clark. “Izzy's been working a lot back there and had a full week,” Campbell said. “And he's gotten a ton of work this week, a ton of reps, full-speed reps. ‘This is what you're going to do, this is the calls’ and just dousing him with full-speed reps and he's done a good job this week.” Safety depth is the bigger concern. The team is expected to count on some combination of Jalen Mills, who signed to the practice squad on Monday, Bishop Fitzgerald, the undrafted rookie poached off the Steelers’ practice squad on Tuesday, and rookie cornerback Keith Abney, who doesn’t have experience at safety. “I'll say this about Abney, man, for a rookie, he's a pretty dang smart, conscientious, aware football player that's got a ton of room to really take off,” Campbell said. “…He's young. He's another one, he just needs reps and reps. But, if we need it, that'll be a guy who may have to go in for us.” You can check here for the full injury report, with game designations, later this afternoon. Reflecting on the past Responding to comments made by Jets coach Aaron Glenn this week, Campbell reflected on his earliest days with the Lions, before the coaching staff had been fleshed out and it was just he and Glenn at the facility working through what they wanted things to look like. “It was just he and I in the lab,” Campbell said. The coach said the two would fill the whiteboard that remains in current coordinator Kelvin Sheppard’s office top to bottom with notes about philosophy, coaching style, team identity and the type of players they wanted to target. “He looks different than me,” Campbell said. “I'm taller, I'm whatever. He's quicker. All these different things, man, but we're really the same. I mean we're so much the same. And he's the defensive version, I'm the offensive version. He was my right hand man. …It was fun, man. Those were good days.” Campbell said it was one of the best and worst days of his life when the Jets hired Glenn to be their coach. “AG means the world to me,” Campbell said. “He's one of my dearest friends because I know what he's made of. “…It's because you know you're losing a little piece of you. That's what he meant to me and to us. So, that's hard.” Traits under center A couple of weeks back, Sheppard noted that Brunell had identified Saints quarterback Tyler Shough as the best prospect at the position ahead of the 2025 draft. On Friday, Brunell confirmed his evaluation and explained what he looks for when studying a young quarterback. Here’s the full answer: “Young quarterbacks, you have to look at everything, you know? I look at guys coming out of college just like I look at any free agents that we might be looking at, or guys that we might add to our roster. Do they take care of the ball? Are they on time? How is their decision-making? How are their feet? “It's tough because you look at a college player, you don't understand what they're trying to do offensively, what their reads are, but you can identify when a guy is accurate, obviously, and when the ball's getting there on time. If there are a lot of interceptions, it raises a red flag. And I think with a lot of the spread offenses of what you're seeing, when you see a young player and they're running some pro concepts and he's having to make protection calls, and he's getting the right play out of the run game, and when there's a lot on his plate and he's executing it very well, and he's managing all of that, that really jumps out at you. It’s really hard to find. “That's one thing we saw with Luke Altmeyer. He had a lot of experience. We call it, ‘Hey, he's playing quarterback.’ And what does that mean? It's not just completing passes. It's getting guys lined up, getting the right play, getting the protection call right, just fixing some problems, being able to progress (through reads). And there's still some young guys out there that can do that at a high level, which is good to see.” Regarding Altmyer, who competed for the team’s backup job through the offseason and currently resides on the practice squad, Brunell acknowledged physical development slows once the season starts, because there aren’t reps to go around. However, there’s still extensive mental development that’s ongoing. “The key for him is approach the game as if you're the starter, mentally,” Brunell said. “And that's really all you can do. Approach the game as if you're the starter and be good in the (class)room. You come in alongside Jared (Goff), and you come in alongside Josh (Dobbs) and (do) whatever they need. And if you get an opportunity to talk to Luke, he'll tell you he does have a lot of responsibilities besides just getting donuts for us on Saturday. “For him, it's mentally staying focused, and even though there's really no chance this Sunday of him playing, he has to approach it as if he's taking the first snap and playing the whole game. So what's our game plan? What are our checks? What are we anticipating? And then during the game, we keep him involved as far as looking at coverages and pressures. And so, really, for him, it's just a mental game. And for now, that's all we can do.” Reason for more zone The Lions have significantly increased their usage of zone coverage on defense this season. I asked Campbell if that was a reaction to their personnel or driven by the focus to generate more turnovers, given it can be easier to produce interceptions when you can keep eyes on the quarterback while playing zone. “I think it was a little bit of both,” Campbell said. “We just felt like this would suit us a little bit better up to this point, and then be disruptive and get takeaways, which worked well Week 1. We had two (opportunities) last week against Buffalo we weren’t able to get, but they’re there.” I followed up by asking how much the combination of heavy blitzing with the back end playing zone has contributed to some of the early-season coverage woes, since adding extra players to the pass rush means leaving the coverage short-staffed. “I mean, it’s challenging, and that’s why a lot of the things we’ve done in zone, for the most part, have been to reduce that stress level back there,” Campbell said. “But that also requires the front getting there. And if you don’t get there, we already kind of talked about that, but there (has to be) a trust there.” The alternative, Campbell explained is sending four and it taking longer for the rush to get home, which can create different problems for a defense. “You can bleed yards,” Campbell said about the strategy. “It gets a little longer and it’s dink-and-dunk and run after catch. …So, we do what we think is right by what we feel like our personnel (does well). But also the game plan, who you’re going in to play, the matchups, their offense. “We’re not stuck on one way.” Detroit Football Network is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
After seven years, a spacecraft company is releasing its Otters into the wild
There is always a tension that comes with seeing the first of anything fly."
iPad Mini 8 Leaked: A20 Pro Chip, Landscape Camera, and More
Apple's next-generation iPad mini will feature the A20 Pro chip, a rearranged front-facing camera, and a new speaker system, leaked code reveals. The information originates from Apple's own code (spotted by MacRumors contributor Aaron Perris) and also shows clear product images of the new iPad mini. Although images of the device only show the front, leaving any design changes of the rear or side profile unknown, there are still visible changes.
Exclusive: First Look at HomePod Mini 2 in Three New Colors
Apple's new HomePod mini will share the same design as the original model and come in five colors, MacRumors has found. The information originates from Apple's own code (spotted by MacRumors contributor Aaron Perris) and shows clear product images of the new models in all of their colors. The above image contains Apple's own icons, which specifically refer to a "HomePod mini 2". The new HomePod mini will come in green, pink, blue, white, and black.
‘Forgotten Island’ review: A mythical memory worth making
Staying out all night and partying with your childhood best friend is a surefire way to savor the fragility of youth. But a send-off party that turns into a night
After training thousands of students, Chicago hairstylist passing on family business
College football has never been better. So why are its leaders set on a 24-team playoff that could ruin the sport?
Taylor Swift releases 4 new songs, including 'Patient Zero'
Taylor Swift's 'The Life of a Showgirl: The Encore' (Mert Alas & Marcus Piggott)
Mets close out 2026 season against Nationals
The season ends with a whimper as the two bottom teams in the NL East face off looking to escape the cellar.
Woman kidnapped at gunpoint outside Roseville business, held for hours, police say
Med Center Health celebrated Cal Turner Rehab & Specialty Care's 30th Anniversary in Scottsville
Email newsletter signup Polls What is the biggest challenge facing Bowling Green? Vote Now View Results
Grizzlies' Most Realistic 2026-27 Outcome Could Be Ideal
The Grizzlies may hover around the Western Conference play-in race in 2026-27, an outcome that could balance development with favorable lottery positioning.
Propane Personality: Lucy Shaffer's path back to the family propane business
Lucy Shaffer, fifth-generation marketing and communications associate at Shaffer's Bottled Gas, shares her journey back to the family propane business.
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “NewCo” model. In a lawsuit originally filed in New York state court and recently moved to federal court, China’s Lepu Medical Technology has alleged that biopharma business development consultant Su Zhang, who was hired to help shop its GLP-1 weight-loss candidates to Western partners, engaged in corporate double-dealing and trade secret leaks. According to the complaint, while acting as Lepu’s primary dealmaking liaison for a group of obesity and metabolic disease drug candidates, Zhang was secretly double-dipping as the acting chief business officer for a direct competitor, BrightGene Pharmaceutical. “She never adequately disclosed the role, never sought Lepu’s consent, and never proposed any safeguard,” Lepu alleged in its complaint, which was filed in July after Zhang’s consulting firm, CoDevCo, sought certain transaction-based success fees from its angry customer through an arbitration process in Singapore. Lepu, the parent company of Lepu Biopharma, has asked Zhang to pay back its $500,000 retainer and disgorge all benefits she received during the alleged breaches of fiduciary duty, plus other damages and relief. The company has also requested the court grant injunctions to protect Lepu’s trade secrets. The ill-fated partnership officially kicked off in December 2024, when Lepu tapped CoDevCo as its “exclusive business development mechanism” to identify collaborators for the company’s drug candidates. According to Lepu’s complaint, Zhang personally negotiated and signed the agreement as managing director for CoDevCo, which used her home address. Before the Lepu deal, Zhang made a name following a short stint as the global head of business development for Hengrui Pharmaceuticals. It was during her tenure that Hengrui signed a landmark deal granting exclusive rights for a portfolio of GLP-1 assets to Hercules, which was at that time newly established by a group of private equity and venture capital firms. In addition to the regular upfront and milestone payments, Hengrui also gained an equity stake in Hercules, which later became Kailera Therapeutics. The Hengrui-Hercules deal opened a new paradigm, where a Chinese biopharma company spins off certain early-stage assets to investors for further development through the creation of a new company abroad. The “NewCo” model quickly came into vogue as it allows Western investors to access high-potential assets originating from China at an early stage while giving the Chinese licensors an opportunity to reap long-term benefits through equity stakes in the new firms. The NewCo model proved its value when Kailera staged a record-breaking $625 million IPO on Nasdaq this April, merely two years into the Hengrui deal. Related Kailera CEO 'knew we were in a good spot' before obesity biotech's record-breaking $625M IPO On her LinkedIn page, Zhang described her work at Hengrui as “[b]uilding team and capability from the ground up,” forming NewCo and major pharma partnerships worth billions of dollars. Lepu clearly wanted that kind of track record to help boost its own cardiometabolic portfolio, which includes a range of assets for obesity, Type 2 diabetes, fatty liver disease and muscle preservation during weight loss treatment. “Lepu’s pipeline is very valuable, but only if Lepu could secure the right international partner to expand into the overseas market during the available commercial window,” the company argued in its complaint. The Chinese biotech said it had little knowledge of U.S. laws, customs or business practices in the business development field, and therefore “needed to rely entirely” on the expertise of Zhang and her team as the firm’s first engagement of a U.S.-based BD consultant. “Zhang’s dominating influence on the business development strategy is further evidenced by the fact that she personally controlled the business-development communications on behalf of Lepu with potential partners,” Lepu said in its complaint. After entering the deal, Zhang introduced Lepu to her four associates. According to Lepu’s version of events, all of them were allegedly employed at different time points to perform similar jobs at other Chinese companies that Lepu described as its competitors, while having access to Lepu’s confidential information. As such, Lepu described Zhang’s team as “a roster of individuals whose primary professional loyalty, by virtue of their concurrent full-time employment, ran to Lepu’s competitors.” As well as the specific examples set out in the case, a look at Lepu’s deals over the period suggests Zhang may have been involved in at least one transaction. During their partnership, Lepu, through its subsidiary Shanghai Minwei Biotechnology, also out-licensed its GLP-1/GIP/FGF21 agonist MWN105 to a NewCo called Sidera Bio in the fall of 2025. The deal included an upfront and near-term payment of $35 million, up to $1.01 billion in milestones, and a 9.99% stake in the Danish startup. It seems likely that Zhang facilitated the Minwei deal given that Lepu is on record as having used CoDevCo as its “exclusive business development mechanism.” The big shock for Lepu came in the form of a news article on June 25, 2025. The article, reporting on phase 2 data for BrightGene’s GLP-1/GIP receptor agonist BGM0504, identified Zhang as acting chief business officer of the Lepu rival. Blindsided by her association with BrightGene, Lepu confronted Zhang in July 2025. “Lepu was given assurances that there was nothing to be concerned about and told that Zhang would explain the matter to Lepu,” Lepu alleged in its complaint. “Zhang never did.” Lepu claimed that Zhang had the motive and opportunity to steer potential prospective partners toward BrightGene or other competitors. Later, in February 2026, one of Zhang’s associates joined BrightGene as the vice president for global business development, according to the complaint. Around the same time, Lepu sent written demand letters asking Zhang to account for her BrightGene role, identify what confidential data were shared with the rival firm, and provide any conflict-of-interest or firewall policies during the engagement. According to Lepu, neither CoDevCo nor Zhang answered the questions in their responses. Related Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight In a motion to dismiss filed with the U.S. District Court in the Eastern District of New York on Sept. 4, Zhang’s legal team argued that Lepu’s agreement was signed with CoDevCo, and that an employee of the contractor does not owe fiduciary duties to the client. In its complaint, Lepu said: “That CoDevCo was the contracting entity does not insulate Zhang from personal liability for duties she personally undertook and personally breached.” Taking the argument one step further, the defending party argued that the consulting agreement “does not create a fiduciary relationship even between CoDevCo and Lepu; instead, it identifies CoDevCo as an independent contractor retained to market Lepu’s business to potential western partners.” Although CoDevCo was Lepu’s exclusive business-development contractor, there were no terms stipulating that the consulting firm should serve only Lepu, Zhang’s lawyer noted. As to Lepu’s claims that Zhang misappropriated trade secrets, the defendant argued that Lepu authorized the use of the information so Zhang’s team could perform their service per the agreement. In a rebuttal filed on Sept. 11, Lepu’s lawyer set out why they believe the Chinese biotech satisfied New York law’s misappropriation definition by alleging that the defendant used a trade secret “in breach of a duty or through improper means.” As an alternative to dismissing the suit, the defendant suggested the action should be stayed pending outcomes from the arbitration of a separate case in Singapore. While NewCo pioneer Zhang is defending her business arrangements, momentum behind the NewCo trend has continued unabated into 2026. Through August, Chinese biotech assets have spurred 15 NewCo deals this year, according to local trade publication PharmaDJ.
Friendly, another poor showing for Ancelotti's Brazil
Brazil got away with one...In their first match since the 2026 World Cup, Brazil faced Australia in a friendly this Friday at noon.Three months after their unfortunately historic round-of-16 eliminati...
Celtic 13th in Europe for home league admissions
Scottish Premiership crowds topped four million for the first time last season as the league continues to attract the highest per capita attendances in Europe reports the BBC Sport Scotland…Celtic s...
Mets Have A Chance To Escape Basement This Weekend
The New York Mets are in Washington to play the Nationals in a battle of bottom-dwelling teams.
The Book Bird credits DeKalb County resources with helping its business grow
Small Business Opportunity Week highlights help for DeKalb entrepreneurs
Aston Villa defender Scott signs first professional deal
Aston Villa defender Katie Scott has signed her first professional contract with the club.WSL Full-Time were informed of the news via an official club press release from The Villans this morning.The 1...
Are girls more social from birth?
Madeleine Finlay sits down with her co-host and Guardian science editor, Ian Sample, to discuss three science stories from the week, including a study that offers a clue in the age-old debate about whether sex differences are present from birth or a product of socialisation. Also on the agenda is the super El Niño, which is predicted to lead to 450,000 deaths in the next six months, and an answer to why the UK’s meningitis outbreak earlier this year was so big.
Trump picked a fight with the media... and lost
Jonathan Freedland speaks to the Guardian’s Shrai Popat about why Trump seems weaker these days, and why it could be dangerous to underestimate him
Matt LaFleur on ugly loss to Falcons: "It was a butt-whooping"
Former Vanillaware veteran Takafumi Noma on new action RPG DAWNGAZER and building a transmedia fantasy IP that will “accommodate all kinds of stories and forms of gameplay”
Trump to headline "Golden Age" event with top officials, tech executives
WNBA playoffs 2026 tracker: Standings, clinch scenarios, schedule, playoff bracket and more
George Kittle weighs in on 49ers’ surprising early success
San Francisco 49ers tight end George Kittle weighs in on the team's early success.It’s only been about three weeks into the NFL season, and no team might be hotter than...